chr19-3478477-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001136503.2(SMIM24):c.181G>T(p.Ala61Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000633 in 1,547,610 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001136503.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMIM24 | ENST00000215531.6 | c.181G>T | p.Ala61Ser | missense_variant, splice_region_variant | Exon 3 of 4 | 1 | NM_001136503.2 | ENSP00000215531.4 | ||
SMIM24 | ENST00000587847.1 | c.-30G>T | splice_region_variant | Exon 2 of 3 | 1 | ENSP00000465692.1 | ||||
SMIM24 | ENST00000587847.1 | c.-30G>T | 5_prime_UTR_variant | Exon 2 of 3 | 1 | ENSP00000465692.1 | ||||
SMIM24 | ENST00000591708.1 | c.-30G>T | 5_prime_UTR_variant | Exon 1 of 2 | 2 | ENSP00000467484.1 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 151940Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000910 AC: 14AN: 153832Hom.: 0 AF XY: 0.0000856 AC XY: 7AN XY: 81784
GnomAD4 exome AF: 0.0000279 AC: 39AN: 1395670Hom.: 0 Cov.: 31 AF XY: 0.0000334 AC XY: 23AN XY: 688478
GnomAD4 genome AF: 0.000388 AC: 59AN: 151940Hom.: 0 Cov.: 31 AF XY: 0.000458 AC XY: 34AN XY: 74206
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.181G>T (p.A61S) alteration is located in exon 3 (coding exon 3) of the SMIM24 gene. This alteration results from a G to T substitution at nucleotide position 181, causing the alanine (A) at amino acid position 61 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at